Extra-pulmonary tuberculosis (TB) presents a significant challenge in the fight against this infectious disease. Unlike the more common pulmonary TB, which affects the lungs, extra-pulmonary TB targets other parts of the body, such as the lymph nodes, spine, brain, and kidneys. This form of TB can be harder to diagnose because its symptoms often mimic other diseases, leading to delays in treatment. Furthermore, extra-pulmonary TB can cause severe complications and requires a longer, more complex treatment regimen. The rising incidence of this type of TB highlights the need for increased awareness, improved diagnostic tools, and better access to effective treatments to manage and ultimately overcome this public health issue.
Tag: GS-1
In News: Pulmonary tuberculosis mainly impacts the lungs, yet approximately 20% of TB infections manifest in other body parts like lymph nodes, the brain, gut, and eyes. Even after resolving lung infections, these organs can still harbor TB, posing a substantial public health challenge, potentially underreported, known as extra-pulmonary TB (EPTB).
Global and Regional Burden of Tuberculosis
- Prevalence Overview
- The World Health Organization (WHO) reports over 10 million new TB cases annually, with India accounting for 27% of the global TB burden.
- Challenges in Estimating EPTB Burden
- Estimating the burden of Extra-Pulmonary Tuberculosis (EPTB) is challenging due to difficulties in diagnosis, leading to underreporting and hidden prevalence.
Focus on Pulmonary TB
- Epidemiological Focus
- Given the predominant burden of pulmonary TB, efforts towards its elimination are prioritized due to its role in disease transmission.
- Importance of Addressing EPTB
- While pulmonary TB remains a priority, the substantial impact of EPTB on affected individuals necessitates attention to its complexities and challenges.
Challenges in Tackling EPTB
- Lack of Physician Awareness
- Many physicians lack awareness of the association between TB and various organs affected by EPTB, leading to underdiagnosis and inadequate treatment.
- Diagnostic and Treatment Limitations
- Challenges exist in accurately diagnosing and treating EPTB, compounded by the absence of standardized protocols for different affected organs.
- Dormancy of INDEX-TB Guidelines
- Guidelines for EPTB management, such as INDEX-TB, formulated in 2014, remain underutilized and require updates based on current evidence and experience.
- Data Fragmentation
- Fragmented data practices among specialist departments hinder comprehensive understanding and management of EPTB, leading to incomplete prevalence data.
- Persistence of Disease Markers
- EPTB presents challenges due to persistent disease markers even after treatment completion, necessitating further research into disease mechanisms and immune responses.
Way Forward
- Enhanced Data Sharing
- Improved data generation and sharing between TB departments and specialist departments can facilitate better understanding and management of EPTB.
- Research Priorities
- Active research into infection spread mechanisms and immune interactions with organs can lead to early detection of persistent disease markers.
- Utilization of Advanced Tools
- Collaboration among EPTB specialties and utilization of advanced immunological tools can aid in uncovering immune mechanisms and guiding appropriate treatment.
- Guidelines Update and Interdisciplinary Collaboration
- Guidelines and protocols for EPTB management need updating with multidisciplinary input and high-quality clinical trial data. Interdisciplinary collaboration is essential for a holistic approach.
Conclusion
Addressing the complexities of EPTB requires a comprehensive approach, considering its significant impact on public health. Understanding disease mechanisms and enhancing collaboration among stakeholders can improve diagnosis, treatment, and management of EPTB.
Source: TH
FAQs
1. What is extra-pulmonary TB?
Answer: Extra-pulmonary TB is a form of tuberculosis that occurs outside of the lungs. While TB most commonly affects the lungs, it can also affect other parts of the body such as the lymph nodes, bones and joints, kidneys, brain, and spine. This type of TB can be more challenging to diagnose and treat because its symptoms vary depending on the affected area.
2. How is extra-pulmonary TB different from pulmonary TB?
Answer: The main difference is the location of the infection. Pulmonary TB affects the lungs and is contagious through airborne particles when an infected person coughs or sneezes. Extra-pulmonary TB, on the other hand, affects organs other than the lungs and is generally not contagious unless it is present in the throat or larynx. Symptoms and treatment may also differ based on the affected body part.
3. What are the symptoms of extra-pulmonary TB?
Answer: Symptoms of extra-pulmonary TB vary widely depending on the organs involved. For example:
- Lymph node TB: Swelling of the lymph nodes, often in the neck.
- Bone and joint TB: Pain and swelling in the affected bones or joints.
- TB meningitis (brain): Headaches, confusion, fever, and neck stiffness.
- Kidney TB: Blood in the urine, pain in the back or side.
- Spinal TB: Back pain, stiffness, and in severe cases, neurological symptoms like paralysis.
4. How is extra-pulmonary TB diagnosed?
Answer: Diagnosing extra-pulmonary TB can be complex and usually involves several tests. These might include imaging studies like X-rays, CT scans, or MRIs, tissue biopsies, and laboratory tests on samples of blood, urine, or other fluids. Since symptoms can be non-specific and mimic other conditions, doctors often need to use a combination of tests to confirm the diagnosis.
5. What is the treatment for extra-pulmonary TB?
Answer: Treatment for extra-pulmonary TB generally involves a prolonged course of antibiotics, similar to pulmonary TB, but may require a longer duration depending on the severity and location of the infection. Commonly used antibiotics include isoniazid, rifampicin, ethambutol, and pyrazinamide. Sometimes, additional treatments such as surgery or corticosteroids may be necessary to address complications or manage symptoms. Close monitoring by healthcare providers is essential to ensure the treatment is effective and to manage any potential side effects.
In case you still have your doubts, contact us on +91-9773890604.
For UPSC Prelims Resources, Click here
For Daily Updates and Study Material:
Join our Telegram Channel – Edukemy for IAS
- 1. Learn through Videos – here
- 2. Be Exam Ready by Practicing Daily MCQs – here
- 3. Daily Newsletter – Get all your Current Affairs Covered – here
- 4. Mains Answer Writing Practice – here
